Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)

不适用 进行中（已停止招募） NCT01696994

摘要

This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for ovarian cancer. The ovarian cancer screening tests are part of a trial that addresses the screening of four cancer sites, each with their own results record: prostate (NCT00002540), lung (NCT01696968), colorectal (NCT01696981), and ovarian (NCT01696994).

Ovarian Cancer Deaths (Including Primary Peritoneal and Fallopian Tube Cancers)

Events through 13 years of follow-up or through December 31, 2009; median follow-up 11.9 years. · Participants

Ovarian Cancer Death Rates (Including Primary Peritoneal and Fallopian Tube Cancers)

Events through 13 years of follow-up or through December 31, 2009; median follow-up 11.9 years. · Deaths per 10,000 PY

在 BENITIONS 中查看 查看 ClinicalTrials.gov 原文

同一适应症的其他试验

• CryoBalloon Ablation for Treatment of Duodenal Adenomas — Johns Hopkins University
• Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refract — Jennerex Biotherapeutics
• Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III — National Cancer Institute (NCI)
• Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps — National Cancer Institute (NCI)
• Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal — National Cancer Institute (NCI)
• Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating — National Cancer Institute (NCI)

全部试验